On February 19, 2026, Bio-Techne (TECH) disclosed a company insider trading transaction. Director Amy E. Herr sold 1,976 shares on February 17, 2026.
[Recent Insider Transactions]
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share/USD
Total Amount/USD
February 19, 2026
Director
Amy E. Herr
February 17, 2026
Sell
1,976
59.11
116,800
February 5, 2026
Director
Amy E. Herr
February 3, 2026
Sell
16
64.63
1,034.08
February 3, 2026
Executive
Matthew McManus
February 1, 2026
Sell
1,665
64.09
106,700
November 5, 2025
Executive
James Hippel
November 3, 2025
Sell
11,900
62.57
742,400
November 5, 2025
Director
Kim Kelderman
November 3, 2025
Sell
2,303
62.57
144,100
November 5, 2025
Executive
William Geist
November 3, 2025
Sell
4,520
62.57
282,800
August 27, 2025
Director
Robert V. Baumgartner, Roeland Nusse
August 25, 2025
Buy
34,000
21.84
744,300
August 27, 2025
Director
Roeland Nusse
August 25, 2025
Sell
17,000
56.36
960,400
August 27, 2025
Director
Robert V. Baumgartner
August 25, 2025
Sell
17,000
56.21
957,800
August 19, 2025
Director
Kim Kelderman
August 15, 2025
Sell
4,305
53.60
230,700
[Company Information]
Bio-Techne Corporation was founded on July 17, 1981, in Minnesota. Bio-Techne and its subsidiaries operate jointly to develop, manufacture, and sell life science reagents, instruments, and services for the global research, diagnostic, and bioprocessing markets. With its extensive product portfolio and application expertise, the company provides components for scientific investigations in bioprocessing and molecular diagnostics, revealing the nature, diagnosis, etiology, and progression of specific diseases.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | Bio-Techne disclosed one insider trading transaction on February 19
On February 19, 2026, Bio-Techne (TECH) disclosed a company insider trading transaction. Director Amy E. Herr sold 1,976 shares on February 17, 2026.
[Recent Insider Transactions]
[Company Information]
Bio-Techne Corporation was founded on July 17, 1981, in Minnesota. Bio-Techne and its subsidiaries operate jointly to develop, manufacture, and sell life science reagents, instruments, and services for the global research, diagnostic, and bioprocessing markets. With its extensive product portfolio and application expertise, the company provides components for scientific investigations in bioprocessing and molecular diagnostics, revealing the nature, diagnosis, etiology, and progression of specific diseases.